Printer Friendly

Scientists use immune system to reduce prostate cancer risk.

Byline: ANI

Washington, Sept 24 (ANI): Researchers from the University of Michigan Comprehensive Cancer Centre have found a novel way to reduce the genetic risk of prostate cancer.

Typically, vaccines are based on specific antigens and trigger immunity for a specific pathogen.

It is challenging for cancer as the best lymphocytes that generate immunity to cancer are eliminated during development.

The researchers have revealed that rescuing these critical immune system cells can help reduce genetic risk of prostate cancer.

They sought to rescue key lymphocytes - called high affinity cancer-reactive T cells - during their development.

During the study, researchers showed that T cells involved in prostate cancer are deleted because of a gene called lymphotoxin alpha.

When the mice lacked lymphotoxin, these T cells came back. These mice become more resistant to prostate cancer. This result suggests that lymphotoxin can be a good target for immune prevention.

The researchers injected a protein targeting lymphotoxin into cancer-susceptible mice.

Without treatment, all of these mice will develop prostate cancer, and typically by age 6 months half of them will have metastatic cancer that has spread to distant organs. Although the treated mice still developed tumours, none developed metastases after 30 weeks.

"It appears that the rescued T cells delay tumour formation. It may not be that this approach can prevent cancer altogether, but it can delay the process and slow the aggressive growth and spread of cancer," said study author Dr Pan Zheng, associate professor of surgery and pathology at the U-M Medical School.

"There is a certain population with a high likelihood of getting cancer, and we need better strategies to minimize their risk.

This approach may be translated into clinical care for those patients," Zheng added. (ANI)

Copyright 2009 Asian News International (ANI) - All Rights Reserved.

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2009 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Asian News International
Date:Sep 24, 2009
Words:303
Previous Article:AIDS vaccine hailed as 'historic milestone'.
Next Article:Protein that repairs Alzheimer's brain damage identified.
Topics:


Related Articles
Aspirin a day 'cuts cancer'.
Nutrition, genes, and cancer prevention: an interview with Tim Radak, Dr.P.H., R.D.
Exercise may increase ovarian cancer risk.
Childhood dairy intake and adult cancer risk.
Researchers study mushrooms' cancer fighting potential.

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters